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A key stage in the life cycle of C-type retroviruses is the assembly of Gag precursor protein at the plasma membrane of
infected cells. Here we report the assembly of bovine leukemia virus (BLV) gag gene product into virus-like particles (VLPs)
using the baculovirus expression system. Expression of BLV Pr44Gag resulted in the assembly and release of VLPs, thereby
confirming the ability of retroviral Gag polyprotein to assemble and bud from insect cells. Efficient particle formation required
a myristoylation signal at the N-terminus of BLV Pr44Gag. Recombinant baculoviruses expressing matrix (MA) or capsid–
nucleocapsid (CA–NC) proteins of BLV were generated but neither of these domains was capable of assembling into
particulate structures. To assess the compatibility of Gag domains between leukemia and lentivirus groups three different
recombinant chimeras each expressing MA of one virus (e.g., simian immunodeficiency or BLV) and CA–NC of another (e.g.,
BLV or human T-cell leukemia virus type-I) were constructed. Each of the chimeric proteins assembled efficiently and budded
as VLPs, suggesting that the MA and CA domains of these two evolutionary divergent retrovirus groups can be functionally
exchanged without perturbation of Gag VLP formation. The lenti-leukemia chimeric Gag approach has potential for studying
protein–protein interactions in other retroviruses. © 1999 Academic Press
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Bovine leukemia virus (BLV) is a transactivating, onco-
enic retrovirus that causes enzootic bovine leukosis
orldwide in cattle. The disease is characterized by
napparent infection, persistent B-cell lymphocytosis,
eukemia, and lymphosarcoma (Burny et al., 1988), lead-
ng to a decrease in milk production. BLV is structurally
nd biologically similar to human T-cell leukemia viruses
HTLV-I and -II) and simian T-cell leukemia virus, and
hese viruses are, therefore, grouped together as the
LV–HTLV virus group within the Retroviridae family. BLV
as become a model system for animal studies for
TLV-I and -II (Kettmann et al., 1994; Sagata et al., 1985).
he BLV–HTLV group shares the properties of C-type
ssembly and the absence of an “intermediate” submem-
rane layer with lentiviruses such as human and simian
mmunodeficiency viruses (HIV and SIV, respectively)
Nermut and Hockley, 1996). All retroviruses including
LV and HTLV employ a single gag gene product, the
ag precursor polyprotein, as a principal building scaf-
old for virus assembly and budding (Wills and Craven,
991). Retroviral Gag has all the necessary morphoge-
1 To whom correspondence and reprint requests should be ad-
ressed at Institute of Virology and Environmental Microbiology, Mans-
ield Road, Oxford, OX1 3SR, UK. Fax: 01865 281696. E-mail:
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308etic information to mediate intracellular transport, direct
ssembly, and catalyze the budding process (Freed,
998).
The retrovirus particle assembly begins with associa-
ion of Gag polyprotein with the host cell plasma mem-
rane and immature particles bud from the plasma mem-
rane. Viral environment (Env) protein also migrates to
he same site and is incorporated into the budding par-
icle. The events associated with the Gag-mediated bud-
ing appear to be similar among different retroviruses.
ach step of virus assembly requires a great degree of
recision and possibly involves highly specific macromo-
ecular interactions including protein–protein and pro-
ein–RNA interactions (Freed, 1998; Gottlinger et al.,
989; Hunter, 1994). Protein–protein interactions are re-
uired during the self-assembly process, which involves
ligomerization of Gag polyprotein at the plasma mem-
rane and envelopment during budding (Nermut et al.,
998; Yu et al., 1992).
BLV Gag is initially synthesized as a polyprotein pre-
ursor (Pr44Gag) that is endoproteolytically cleaved into
ajor structural subunits, matrix (MA, p15), capsid (CA,
24), and nucleocapsid (NC, p12), during or shortly after
udding (Kettmann et al., 1994). Of these proteins, MA
lays a significant role in virus assembly and membrane
argeting and has a multifunctional role in virus morpho-
enesis (Bryant and Ratner, 1990; Morikawa et al., 1995).
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309CHIMERIC Gag ASSEMBLYoth MA and CA contribute to the packing of Gag
olyproteins during assembly (Dorfman et al., 1994;
ranke et al., 1994; Hunter, 1994; Morikawa et al., 1998;
hang et al., 1996). The linear order of MA, CA, and NC
roteins within the Gag precursor is invariant and the
ssembly domains of different retroviruses may be func-
ionally conserved.
Although different retroviral Gag proteins have similar
unctions, there is little sequence homology among the
ag proteins from evolutionarily divergent retroviruses.
he three-dimensional structures of several retroviral
A proteins have been determined and provide an in-
eresting insight into retrovirus assembly and MA orga-
ization (Christensen et al., 1996; Conte et al., 1997;
onte and Matthews, 1998; Hill et al., 1996; Massiah et
l., 1996; Matthews et al., 1996; Rao et al., 1995). Recently,
he crystal structure of SIV MA (Rao et al., 1995) and NMR
olution structure of BLV MA (Matthews et al., 1996) have
een resolved. BLV MA shows structural homology with
he MAs of SIV and HIV-1. The X-ray crystallographic data
evealed a trimeric nature of SIV and HIV-1 (Hill et al.,
996; Rao et al., 1995). Similar models have been pre-
icted for BLV and subsequently for HTLV-II as well as for
he D-type Mason–Pfizer monkey virus (M-PMV) MA pro-
eins (Christensen et al., 1996; Conte et al., 1997; Mat-
hews et al., 1996). The high level of similarity among the
As of these retorviruses suggests a common mode of
ransport and assembly of Gag polyprotein at the plasma
embrane. The conservative nature of the MA structure
nd linear order of the Gag protein products raise the
ssue of whether MA and CA–NC proteins of different
etroviruses are compatible.
Many heterologous expression systems have been
sed for analysis of the retrovirus particle assembly and
elease (Boulanger and Jones, 1996). Of all the systems,
he baculovirus system appears to be the best for retro-
iral Gag expression and thus has been used extensively
or studying the assembly and release of virus-like par-
icles (VLPs) in bovine immunodeficiency virus (BIV), fe-
ine immunodeficiency virus (FIV), HIV-1, and SIV (Del-
hambre et al., 1989; Cheysen et al., 1989; Morikawa et
l., 1991; Rasmussen et al., 1990). However, to date, no
eports are available on the expression of either BLV Gag
r VLPs made of heterologous components using a bac-
lovirus expression system although recombinant vac-
inia virus has been previously demonstrated to produce
LV Gag VLPs (Hertig et al., 1994).
The present study was, therefore, undertaken to inves-
igate the synthesis of BLV Gag particles in insect cells
sing a recombinant baculovirus system and to study the
fficiency of BLV MA or CA–NC proteins to direct pro-
ein–protein interactions to assemble into particulate
tructures. The importance of the N-terminal myristoyl-
tion of BLV Gag was investigated by mutating the site of
yristoylation (Gly2 3 Ala) and expression of mutant
ag in insect cells. Subsequently the compatibility of MA tnd CA–NC domains of different viruses, BLV, HTLV-I,
nd SIV, was assessed by monitoring VLP formation by
omain-switched chimeric Gag particles.
RESULTS
ssembly of BLV Gag and formation of virus-like
articles in insect cells
The baculovirus expression system has been used
xtensively to analyze lentiviral Gag precursor assembly.
owever, it has yet to be demonstrated that the Gag
olyprotein of a leukemia virus (BLV–HTLV) group has a
imilar inherent property of VLP assembly in insect cell
ultures. To determine the protein–protein interactions
equired for BLV and HTLV Gag assembly, it was impor-
ant to develop an assay system that will facilitate de-
ection of particle formation. To establish such a system,
recombinant vector, pAcBgag, was therefore con-
tructed (Fig. 1A) by cloning full-length BLVgag into
AcYM1 and recombinant baculovirus AcBgag obtained
s described under Materials and Methods.
The expression of the BLV Gag polyprotein by recom-
inant baculovirus in infected insect cell lysate was
onitored by Western blot analysis (Fig. 2A, lane 2). The
xpressed protein was approximately 44 kDa and it cor-
esponded to the predicted size of the BLV precursor
ag (Pr44Gag). The expressed protein reacted specifically
ith a polyvalent anti-BLV serum and had an electro-
horetic mobility similar to that of the 44-kDa protein
and of fetal lamb kidney cells infected with BLV (FLK/
LV cells) (Fig. 2A, lane 6). To determine whether this
ecombinant Pr44Gag could assemble and subsequently
e released into the medium as VLPs, we used sucrose
ensity gradient fractionation as a standard method of
ag VLP isolation. The gradient fractions were collected
nd examined for BLV Pr44Gag by Western blot (Fig. 3,
anes 2–11). Although some protein was pelleted as
ggregate (Fig. 3, lane 11), the majority of the Gag protein
egregated in fractions 5 to 8, corresponding to 35–45%
ucrose (Fig. 3, lanes 6–9), equivalent to the positions of
he HIV/SIV Gag particles (Gheysen et al., 1989; Jowett et
l., 1992), indicating that the AcBgag expressed BLV
r44Gag polyprotein assembled and was released as a
articulate structure in the culture supernatant.
Electron microscopy was performed to monitor the
orphology and the site of budding of VLPs. BLV Gag
rotein synthesized in insect cells assembled into VLPs
nd appeared to bud from the plasma membrane in a
anner typical of C-type retroviruses (Fig. 4A). However,
number of VLPs formed tubular structures of different
engths and about 90 nm in diameter as opposed to 110
m in diameter for the spherical forms (Fig. 4B). The
mmunogold labeling of the thin-sectioned infected in-
ect cells confirmed these VLPs and the tubular struc-ures to be of BLV origin (Figs. 4C and 4D).
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310 KAKKER ET AL.yristoylation is essential for BLV Pr44Gag assembly
nd budding
The Gag protein of most retroviruses, including BLV, is
yristoylated at the N-terminal glycine residue and plays
n essential role in targeting the Gag precursor to the
ell membrane and in the subsequent assembly and
udding of extracellular particles (Towler et al., 1988). To
xamine the role of myristoylation in the process of
ssembly and budding of BLV Gag, a mutant transfer
ector, pAcBgagmyr-, was constructed altering GCA for
GA (Fig. 1B) by site-directed mutagenesis as described
nder Materials and Methods. This mutation exchanged
la for the myristate acceptor Gly (Gly2 3 Ala), thereby
reventing myristoylation of the BLV Gag precursor
myr-
FIG. 1. Schematics of Gag polyprotein constructs used to generate
espective Gag protein is shown on the left. Source of Gag protein in e
G and H) HTLV-I (hatched box). The major domains are numbered wit
B) indicates the mutation of the second codon to code for Ala. Arrowolyprotein. The transfer vector pAcBgag was used to Gotransfect Spodoptera frugiperda (Sf) cells and recom-
inant baculovirus AcBgagmyr- was obtained as de-
cribed.
Sf cells infected with AcBgagmyr- expressed a recom-
inant protein of 44 kDa that corresponded to wild-type
LV Pr44Gag and reacted specifically with polyvalent rab-
it anti-BLV serum in Western blot (Fig. 2A, lane 4). The
xpression level of unmyristoylated Gag protein was
imilar to the wild-type BLV Gag. To investigate the par-
iculate nature of the mutant BLVgag gene product, the
ulture supernatant was analyzed for the presence of
4-kDa antigen after concentration through a 20% su-
rose cushion. No BLV protein could be detected in the
ulture supernatant (Fig. 2A, lane 5). To locate the BLV
myr- myr-
inant transfer vectors. The recombinant transfer vector encoding the
nstruct is indicated as (A) BLV (empty box), (E) SIV (shaded box), and
starting and ending residues in the respective Gag protein. Black bar
F, G, H, I) indicate the fusion protein junction.recomb
ach co
h theirag protein within AcGgag infected cells, Sf cells
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311CHIMERIC Gag ASSEMBLYere processed for thin-section electron microscopy.
he unmyristoylated Gag protein was not found at the
lasma membrane and no budding particles were visu-
lized (results not shown). These results indicated that
cBgagmyr- infected cells expressed a BLV protein similar
n size to wild-type Pr44Gag that was unable to assemble
s VLPs at the plasma membrane of insect cells.
either BLV MA nor CA–NC alone is sufficient for
ssembly and release
The retroviral MA is important for the targeting and
ssembly of viral structural proteins at the plasma mem-
rane of infected host cells. The SIV MA protein has
een reported to be sufficient for the production of par-
iculate structures when expressed by a vaccinia virus
ystem (Gonzalez et al., 1993). These observations have
een recently confirmed (Giddings et al., 1998). However,
sing the same expression system HIV-1 MA failed to
FIG. 2. Western analysis of BLV Gag expression and particle release in
nsect cells. Protein samples were resolved either on a (A) 10% or on a (B)
5% SDS–PAGE: (A) Mock-infected Sf cells (lane 1); BLV Pr44Gag in the cell
ysate (lane 2, note some breakdown products that are common for
etrovirus Gag expression in Sf insect cells) and supernatant (lane 3); Pr44
agmyr- in the cell lysate (lanes 4) and supernatant (lane 5; note the
bsence of BLV Gagmyr- in the supernatant); cell lysate from BLV infected
LK cells (lane 6). (B) Presence of BLV MA p15 (lane 2) and CA–NC p36
lane 4) in the cell lysate indicated by arrowheads. Note that both proteins
re absent in the supernatant (lanes 3 and 5). Lanes 1 and 6 are the
ock-infected Sf cells and purified BLV Pr44Gag, respectively. The position
f molecular weight markers is indicated on the left.ssemble into a particulate structure in the absence of ither viral molecules (Giddings et al., 1998). No reports
re available so far to demonstrate the capability of
ncoviral (BLV/HTLV) MA alone to assemble into such
tructures. To assay whether individual domains of on-
oviral Gag form particulate structures like SIV MA, we
ave dissected BLV Gag into two domains, MA and
A–NC. To investigate whether BLV MA or CA–NC in the
bsence of all other viral proteins forms particulate struc-
ures, we generated two recombinant baculoviruses,
cBma and AcBca-nc, that expressed only the MA (Fig.
C) or CA–NC (Fig. 1D) protein of BLV.
Sf cells infected individually with AcBma or AcBca–nc
xpressed BLV MA protein of 15 kDa (p15, Fig. 2B, lane
) or CA–NC protein of 36 kDa (p36, Fig. 2B, lane 4),
espectively, that specifically reacted with polyclonal rab-
it anti-BLV serum in Western blots. To monitor the re-
ease of particulate structures, the culture supernatant
rom infected Sf cells was concentrated through a 20%
ucrose cushion and the pelleted material was analyzed
or the presence of p15 or p36 antigen. By Western
nalysis using polyclonal rabbit anti-BLV serum we failed
o detect any of the p15 (Fig. 2B, lane 3) or p36 (Fig. 2B,
ane 5) antigen. These results indicated that BLV MA or
A–NC protein is not released into the culture medium
s particulate structures.
Recombinant BLV MA or CA–NC protein was also
xamined within the infected Sf cells by thin-section
lectron microscopy. As expected, no VLP assembly or
udding particles were detected at the plasma mem-
rane of cells expressing BLV MA or CA–NC protein
results not shown). However, a few rings and small
esicles containing dense material were found in cyto-
lasmic vacuoles in Sf cells infected with AcBma. Immu-
ogold labeling of AcBca–nc infected cells with a poly-
lonal rabbit anti-BLV antibody also demonstrated that
he CA–NC protein was synthesized in sufficient
mounts within the cytoplasm but failed to assemble and
ud as particulate structures (Fig. 5A). In some cells long
undles of closely packed parallel structures (possibly
ross sections of flat sheets) were observed, which also
abeled with anti-BLV antibody (Figs. 5A and 5B), indicat-
ng that the recombinant products were concentrated as
FIG. 3. Western analysis of sucrose density gradient fractions of BLV
r44Gag. The fractions were collected from top to bottom (fractions 1 to
0). Sf cell lysate expressing BLV Pr44Gag, lane 1; top fraction, lane 2;
nd bottom fraction, lane 11. The position of molecular weight markerss indicated on the left.
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312 KAKKER ET AL.aracrystalline structures. These results indicated that
lthough abundant protein was synthesized, BLV MA
lone or MA-deficient BLV CA–NC was unable to assem-
le as particulate structures at the plasma membrane of
nfected insect cells.
himeric Gag polyproteins consisting of SIV, BLV, and
TLV-I domains in insect cells assemble into VLPs
Recent X-ray crystallography and NMR structural anal-
sis demonstrated that the MA proteins of SIV/HIV and
LV/HTLV share similar structures, although these pro-
eins are quite distinct at the primary sequence level
Christensen et al., 1996; Hill et al., 1996; Matthews et al.,
996; Rao et al., 1995). To investigate whether the MA
nd CA–NC domains of two distinct members of the
etroviridae would complement and could be exchanged
ithout perturbing Gag particle formation, three different
himeric constructs were designed. In two of these con-
tructs the MA domain was derived from SIV, while in the
hird, MA was derived from BLV. However, for the first
himera, the CA–NC was derived from BLV, while the last
wo contained HTLV-I CA–NC. The cloning of two frag-
ents (MA and CA–NC) in one vector would lead to
nsertion of six additional nucleotides (GGATCT) at the
unction of MA 1 CA–NC. To ensure that the coding
egion of chimeric gag is not influenced by the cloning
rocedure, as a control, using the same two BLVgag
ene fragments (MA and CA–NC), were constructed an-
ther vector, pAcBBgag (Fig. 1I), and obtained recombi-
ant baculovirus, AcBBgag. Western analysis of infected
ell lysate (Fig. 6A, lane 2) and sucrose density gradient
urified Gag VLPs from culture supernatant (Fig. 6A, lane
) indicated that the two additional amino acids at the
unction of MA 1 CA–NC did not affect the ability of the
ag protein to form VLPs.
Further, as a positive control, the full-length SIVgag
ene was also cloned in pAcYM1 constructing pAcSgag
Fig. 1E) and recombinant virus AcSgag was obtained.
hen a AcSgag infected Sf cell lysate was analyzed, as
xpected, a 57-kDa (Pr57Gag) protein was clearly identi-
ied, which specifically reacted with polyclonal monkey
nti-SIV serum in Western blot (Fig. 6B, lane 4). Similarly,
nalysis of sucrose density gradient purified SIV Gag
LPs demonstrated the presence of SIV Pr57Gag (Fig. 6B,
ane 5). Thin sections of infected cells by electron mi-
roscopy confirmed the assembly and budding of VLPs
t the plasma membrane similar to published reports
Delchambre et al., 1989; Gonzalez et al., 1993). Subse-
uently, recombinant viruses AcSBgag, AcSHgag, and
cBHgag expressing SIV MA 1 BLV CA–NC, SIV MA 1
TLV-I CA–NC, and BLV MA 1 HTLV-I CA–NC, respec-
ively, were derived and Gag polyprotein formation was
nalyzed as described.
Sf cells infected with recombinant chimeric virus AcS-FIG. 4. Electron micrographs of infected Sf cells showing the expres-
ion, assembly, or budding of BLV Gag proteins. Thin section of bud-
ing and free VLPs of Sf cell expressing BLV Pr44Gag (A); same after
mmunogold labeling with polyclonal antibody to BLV (C); some cells
lso demonstrated assembly and budding of tubular structures at the
lasma membrane (B); same after immunogold labeling (D). Bar rep-gag expressed a 46-kDa protein that bound specifically
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313CHIMERIC Gag ASSEMBLYoth to polyclonal rabbit anti-BLV serum (Fig. 6A, lane 6)
nd to monkey anti-SIV serum (Fig. 6B, lane 6) in Western
lots, confirming its chimeric nature. The expressed pro-
ein had a faster electrophoretic mobility than SIV Gag
Fig. 6B, lane 4) but a slower electrophoretic mobility
han BLV Gag (Fig. 6A, lane 2) did. Likewise, cells in-
ected with AcSHgag expressed a 52-kDa protein that
ad the slowest mobility of all the chimeric polyproteins
Fig. 6B, lane 8). The AcBHgag infected Sf cells ex-
ressed a protein of 44 kDa that specifically reacted with
FIG. 5. (A) Closely packed parallel sheets in cells expressing CA–
C; (B) same after immunogold labeling with a polyclonal antibody to
LV. Bar represents 100 nm.
FIG. 6. Western analysis of Gag synthesis by homologous and chim
), religated BLV Pr44Gag (lanes 2 and 3), SIV Pr57Gag (lanes 4 and 5), SIV
r44Gag (lanes 10 and 11), respectively. The position of each Gag polyphe polyclonal rabbit anti-BLV (A) or the polyclonal monkey anti-SIV antibodyolyclonal rabbit anti-BLV serum (Fig. 6A, lane 10) and
ad an electrophoretic mobility similar to that of BLV Gag
Fig. 6A, lane 2).
The clarified culture supernatant from each of the
ecombinant chimeric virus infected Sf cells was ana-
yzed for the presence of the respective Gag antigen in
ucrose density gradient fractions as described earlier.
n each case the secreted Gag protein was detected in
ractions 5 to 8 corresponding to 35–45% sucrose and
ome protein was detectable in the pellet as aggregates
imilar to BLV Pr44Gag (data not shown). Each of the
himeric proteins reacted specifically with their respec-
ive polyclonal antisera in Western analysis and exhib-
ted a gel mobility corresponding to their predicted mo-
ecular weights (Figs. 6A and 6B, lanes 7, 9, and 11).
Further, thin sections of infected insect cells in each
ase also showed typical assembly and budding of VLPs
t the plasma membrane. In the case of AcSBgag many
LPs were spherical in morphology and occasionally
udded into cytoplasmic vacuoles (Fig. 7A). Interestingly,
cSHgag infected cells expressed VLPs that were ap-
arently larger and some distinctly larger (140–170 nm)
han average particles (Fig. 7B). The AcBHgag infected
ells demonstrated budding of mainly spherical VLPs
Fig. 7C). In addition, some tubular structures were ob-
erved in each case. From these results it is clear that all
hree chimeric proteins assembled at the plasma mem-
rane of infected cells and budded as VLPs similar to
LV Pr44Gag.
DISCUSSION
Expression of BLV Pr44Gag by recombinant baculovirus
cBgag resulted in the assembly, budding, and release
f VLPs. This is consistent with similar studies on other
entiviruses and leukemia viruses (Delchambre et al.,
nstructs in cell lysates and supernatants. Mock-infected Sf cells (lane
r46Gag (lanes 6 and 7), SIV/HTLV Pr52Gag (lanes 8 and 9), and BLV/HTLV
is indicated by arrowheads. Immunoblots were developed with eithereric co
/BLV P
rotein(B). The position of molecular weight markers is indicated on the left.
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314 KAKKER ET AL.989; Gheysen et al., 1989; Hertig et al., 1994; Morikawa
t al., 1991; Rasmussen et al., 1990) using a variety of
xpression systems. Furthermore, these experiments
emonstrated that retroviral Gag assembly could occur
n the absence of viral enzymatic proteins, envelope
lycoproteins, and genomic RNA.
Gag proteins of most mammalian retroviruses (e.g.
IV, Moloney murine leukemia virus (MuLV), M-PMV, and
IV) require N-terminal myristic acid to become associ-
ted with the plasma membrane prior to budding from
he cell (Bryant and Ratner, 1990; Delchambre et al.,
989; Gheysen et al., 1989; Gottlinger et al., 1989; Rein et
l., 1986; Rhee and Hunter, 1987). We have utilized the
aculovirus system to analyze the role of myristoylation
n assembly of BLV Pr44Gag by expressing the unmyris-
oylated Gag. This mutation abolished VLP assembly and
udding from the plasma membrane but did not interfere
ith the polyprotein synthesis as an unmyristoylated
ag protein of 44 kDa could be detected in cell lysates of
cBgagmyr- infected Sf cells. Similar results have been
eported for HIV-1 and other retroviruses (Mergener et
l., 1992). Mutation of N-terminal Gly codons of MuLVgag
nd SIVgag gene products led to the accumulation of
ag proteins within the cytoplasm without release of
articles in the supernatant of the infected cell culture
Delchambre et al., 1989; Rein et al., 1986). Thus myris-
oylation of BLV Gag polyprotein seems to be essential
FIG. 7. Electron micrographs of thin sections of Sf cells showing th
nfected with recombinant baculoviruses AcSBgag (A), AcSHgag (B), aor the association of the precursor protein with the cell aembrane, which in turn is critical for budding and
elease of Gag particles.
SIV MA alone has been reported to assemble into
articulate structures (Giddings et al., 1998; Gonzalez
t al., 1993). To study whether the BLV MA alone or
A–NC proteins have similar assembly characteris-
ics, we expressed each of these proteins in insect
ells and found that neither of these synthesized pro-
eins was capable of assembling into a particulate
tructure. These results are consistent with the re-
orted findings on HIV-1 MA (Giddings et al., 1998).
lthough BLV MA and CA–NC proteins were ex-
ressed efficiently in infected Sf cells, no particle-like
tructure was visualized at the plasma membrane.
hus, BLV MA alone is insufficient to assemble into
articulate structures. The failure of the BLV CA–NC
omain to assemble and bud as a particulate structure
uggests that the presence of the MA domain is es-
ential for the in vivo assembly of BLV Gag at the
lasma membrane. This result points to the leading
ole of retroviral MA in the plasma membrane assem-
ly of the Gag precursor and formation of the spherical
hell during budding. Retroviral MA has been shown to
lay a decisive role in transport, plasma membrane
ssociation, and formation of the spherical shell
Morikawa et al., 1995; Nermut et al., 1994).
To locate the functional equivalents of retroviral MA
bly and budding of Gag chimeras at the plasma membrane of cells
Hgag (C). Bar represents 100 nm.e assemnd CA–NC in evolutionary divergent retroviruses, we
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315CHIMERIC Gag ASSEMBLYade Gag chimeras. Both lenti-leukemia (SIV MA 1
LV CA–NC and SIV MA 1 HTLV-1 CA–NC) and leu-
emia–leukemia (BLV MA 1 HTLV CA–NC) chimeras
ere capable of assembling VLPs at the plasma mem-
rane of the infected cells. The particles produced by
hese chimeras were similar in morphology to wild-
ype Gag particles. These data are consistent with the
arlier reports that Rous sarcoma virus MA 1 HIV-1
A–NC chimeras were functional for assembly and
udding and that their late assembly domains that
unction in a positional-independent manner can be
xchanged (Bennett et al., 1993; Parent et al., 1995).
owever, retrovirus-like particles were not detected at
he plasma membrane in human spuma retrovirus–HIV
himeras but could be detected within the cell in the
ytoplasm only (Carriere et al., 1995). The chimeric
uLV virions containing either the HIV-1 MA or the CA
omain were inefficiently assembled into mature virus
articles because of improper intracellular targeting
nd were partially defective in the late stage of repli-
ation (Deschamps et al., 1981).
The successful generation of lenti-leukemia and leu-
emia–leukemia functional Gag chimeras suggests that
hese two evolutionary divergent retrovirus groups have
similar arrangement of assembly domains that serve
dentical functions and are interchangeable. Thus the
eplacement of leukemia viral MA with lentiviral MA as in
IV MA 1 BLV CA–NC and SIV MA 1 HTLV-I CA–NC or
eplacement of its CA–NC with other leukemia viral
A–NC as in BLV MA 1 HTLV-I CA–NC had no detri-
ental effects on the assembly capacity of the resulting
ag chimera. Further, the MA domain of one retrovirus
ould modulate the assembly of another as observed in
ll three chimeras even though their sequences within
he Gag precursor are not conserved. These findings
trongly suggest that the surface properties of the rele-
ant domains are the dominant features in protein–pro-
ein interactions.
In conclusion the results in the present study indi-
ate that BLV Pr44Gag assembles into VLPs just like
ther retroviral Gag. However, when we expressed the
nmyristoylated form of BLV Gag, VLP formation was
brogated. BLV MA or CA–NC protein alone was un-
ble to assemble as a particulate structure. All three
enti-leukemia or leukemia–leukemia chimeric Gag
roteins efficiently assembled into VLPs, confirming
hat homologous MA–CA interaction is not essential
or particle formation. These observations raise an
mportant issue about how the different parts of Gag
nteract prior to or subsequent to proteolysis and par-
icle maturation. Further these chimeras have the po-
ential to be used to study in vitro protein–protein
nteractions and design inhibitors of retrovirus assem-
ly. oMATERIALS AND METHODS
ells and viruses
Spodoptera frugiperda (Sf9) cells were propagated in
uspension or monolayer cultures at 28°C in TC-100
edium (Gibco BRL, UK) supplemented with 5% fetal
ovine serum. The wild-type baculovirus Autographa
alifornica nuclear polyhedrosis virus (AcNPV) and the
ecombinant BAcPAK-6 virus containing the lacZ (b-ga-
actocidase) gene under the control of the AcNPV poly-
edrin promoter were used to generate recombinant
iruses (Kitts and Possee, 1993). Fetal lamb kidney cells
nfected with BLV were kindly supplied by L. Willems,
epartment of Biochemistry and Applied Biology, Univer-
ity of Brussels, Gembloux, Belgium.
NA manipulations
Plasmid DNA manipulations were undertaken essen-
ially as described (Sambrook et al., 1989). Polymerase
hain reaction (PCR) was used for amplification of DNA
ragments. PCR products after purification and restriction
nzyme digestion were ligated into pAcYM1 (Matsuura
t al., 1987) and transformed into Escherichia coli XL-1
lue competent cells. Plasmid minipreps were prepared
rom overnight grown cultures of a single bacterial trans-
ormed clone and digested with appropriate restriction
nzymes to check the desired size and correct orienta-
ion of the insert. DNA fragments and plasmids after
igestion were separated on agarose gel and purified
sing a Qiaex II gel extraction kit (Qiagen Inc.). All the
NA mutations and junction sites were confirmed by
ideoxy nucleotide sequencing (Sanger et al., 1977).
onstructions of recombinant and
himeric transfer vectors
All recombinant and chimeric transfer vectors were
onstructed by PCR amplification of DNA fragments and
ubsequent cloning in baculovirus vector pAcYM1 down-
tream of the polyhedrin promoter. Oligonucleotide prim-
rs used for cloning DNA fragments were designed to
nclude a BamHI (GGATCC) or BglII (AGATCT) restriction
ite at their 59 termini (Table 1). BLV, SIV, and HTLV-I
ull-length gag or their DNA fragments were amplified
rom the original clones, pBLVT-15 (Deschamps et al.,
981), p239SpSp59 (SIVmac239 isolate), and pUCES6CH
proviral HTLV-1 cDNA), respectively, to generate the
ecombinant transfer vectors described below.
pAcBgag, pAcBgagmyr-, pAcBma, pAcBca–nc, and pAc-
gag. Recombinant transfer vector pAcBgag (Fig. 1A)
ontaining the full-length (1179 bp) PCR amplified BLV-
ag gene was constructed using forward and reverse
rimers BLVF1 and BLVR394, respectively (Table 1).
AcBgagmyr- (Fig. 1B) was constructed similarly by clon-
ng PCR amplified DNA such that the second DNA codon
f BLVgag at the 59 terminus was mutated (GGA3 GCA)
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316 KAKKER ET AL.o code for Ala. Oligonucleotides BLVF1myr- (forward) and
LVR394 (reverse) were used for generating a 1179-bp
LVgagmyr- DNA. pAcBma (Fig. 1C) and pAcBca-nc (Fig.
D) were constructed by cloning 327- and 852-bp DNA
ragments corresponding to MA and CA–NC region
enes, respectively, of BLVgag. The forward and reverse
rimers used for pAcBma were BLVF1 and BLVR109X,
espectively, with a stop codon (ochre) in the reverse
rimer. For pAcBca-nc the forward primer BLVF110S was
esigned to introduce a start codon at the 59 terminus
nd BLVR394 was used as reverse primer. Recombinant
ransfer vector pAcSgag (Fig. 1E) containing the full-
ength (1530 bp) PCR amplified SIVgag gene was con-
tructed similarly by using forward and reverse oligonu-
leotide primers SIVF1 and SIVR511, respectively (Table
). The PCR generated DNA fragments after restriction
nzyme digestion and purification in each case were
loned at a unique BamHI restriction site of baculovirus
ector pAcYM1.
pAcSBgag, pAcSHgag, and pAcBHgag. Chimeric
ransfer vectors were constructed in two steps. In the
irst step the MA fragment from SIV or BLVgag (contain-
ng a 396-bp fragment of SIVMA or a 327-bp fragment of
LVMA) was cloned individually into pAcYM1 to gener-
te an intermediate transfer vector, pAcSMA or pAcBMA,
espectively. The forward and reverse oligonucleotide
rimers used to generate PCR fragments were SIVF1
nd SIVR132 or BLVF1 and BLVR109, respectively (Table
). In the second step the CA–NC fragment from BLV or
TLV-Igag was cloned in each of the two intermediate
ectors to generate three recombinant chimeric gag
enes in pAcYM1. DNA fragments BLV CA–NC (852 bp)
r HTLV-I CA–NC (897 bp) were synthesized using for-
ard and reverse primers BLVF110 and BLVR394 or
TLVF131 and HTLVR429, respectively (Table 1). These
A–NC fragments were cloned into the BamHI restriction
TABLE 1
Oligonucleotide Primers Used in PCR
Primer Sequencea
LVF1 GCGCAGATCTAAAATGGGAAATTCCCCCTCCTATAACCCC
LVF1myr- GCGCAGATCTAAAATGGCAAATTCCCCCTCCTATA
LVF110 GCGAAGATCTCCAATTATATCTGAAGGAAAT
LVF110S GCGCAGATCTAAAATGCCAATTATATCTGAAGGA
LVR109 GCACGGATCCCAAAATGGCGGGGGGGTCA
LVR109X GCACGGATCCTTACAAAATGGCGGGGGGGTCA
LVR394 GCGCGGATCCTTAGTTTTTTGATTTGAGGGTTGG
TLVF131 GCGCAGATCTCCAGTCATGCATCCACAT
TLVR429 GCGCTTAGGATCCAACCTCCCCCCCTATGAA
IVF1 GAGCAGATCTAAAATGGGCGTGAGAAACTCC
IVR132 GAATGGATCCTCCTCTGCCGCTAGATGG
IVR511 GCGCAGATCTCTACTGGTCTCCTCCAAA
a Restriction enzyme sites are shown in boldface type and mutated
equences (substitution or addition) are underlined.ite of pAcSMA and pAcBMA to construct (a) pAcSBgag lFig. 1F), incorporating MA from SIV and CA–NC from
LV; (b) pAcSHgag (Fig. 1G), incorporating MA from SIV
nd CA–NC from HTLV-1; and (c) pAcBHgag (Fig. 1H),
ncorporating MA from BLV and CA–NC from HTLV-I.
pAcBBgag. A recombinant transfer vector consisting of
he MA fragment and CA–NC fragment of BLV was sim-
larly constructed by cloning the CA–NC fragment of BLV
nto the BamHI restriction site of pAcBMA (Fig. 1I).
otransfection and generation of recombinant viruses
The recombinant baculovirus transfer vectors were
sed for in vivo recombination together with Bsu36I-
inearized BAcPAK-6 DNA. Cotransfection was performed
y the lipofectin (Gibco BRL) method following the basic
rotocol (King and Possee, 1992). The recombinant bac-
lovirus harvested after cotransfection was plaque puri-
ied and propagated in Sf cells (King and Possee, 1992).
iruses were used at a multiplicity of infection of 0.1–0.2
or virus stocks preparation and of 5–10 to detect expres-
ion of recombinant proteins.
DS–PAGE and Western blot analysis
Sf cells were harvested at 48 h postinfection (p.i.),
ashed with phosphate-buffered saline, and treated with
ysis buffer (2.3% SDS, 10 mM Tris–HCl, pH 6.8, 5%
-mercaptoethanol, 10% glycerol) as described else-
here (Hughes et al., 1993). The protein samples were
lectrophoresed on 10 or 15% PAGE containing 0.1% SDS.
or Western blot analysis, proteins resolved by SDS–
AGE were electrophoretically transferred to an Immo-
ilon-P membrane (Millipore International) by standard
lotting procedure (Towbin et al., 1979). The membrane
fter electroblotting was probed with appropriately di-
uted specific antiserum (primary antibody) in blocking
uffer for 1 h. After three washes, the membrane was
ncubated with the secondary antibody conjugated with
lkaline phosphatase and the bound antibody was de-
ected by NBT-BCIP (Gibco BRL).
ucrose density gradient centrifugation
The released particles were isolated from infected cell
upernatant by sucrose density gradient centrifugation
sing the method described previously (Hughes et al.,
993). In brief, supernatant from an infected cell culture
as harvested at 60 h p.i., and cells and cellular debris
ere removed by low-speed centrifugation. The clarified
upernatant was then concentrated through 20% sucrose
n 10 mM Tris–HCl and 1 mM EDTA, pH 8.0 (TE), by
entrifugation at 20,000 rpm for 2 h. The pellet from
igh-speed centrifugation was resuspended in TE and
entrifuged on a 20 to 60% continuous sucrose gradient
t 26,000 rpm for 1 h. One-milliliter fractions were col-ected for analysis.
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317CHIMERIC Gag ASSEMBLYlectron microscopy
Infected Sf cells were harvested after 48 h p.i. and
ixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer,
H 7.2, for conventional embedding in Araldite as de-
cribed previously (Hockley et al., 1988). For gold immu-
olabeling, cells were fixed in 3% paraformaldehyde and
rocessed with the progressive lowering of temperature
rocedure followed by embedding in Lowicryl HM20
sing a CS-Auto unit at 245°C (Reichert-Jung, Vienna).
owicryl sections were gold-immunolabeled with poly-
lonal antibody against BLV Gag protein and poststained
ith alcoholic uranyl acetate for 5–8 min (Nermut and
icol, 1989). Preimmune rabbit serum was used as a
ontrol.
ntisera and enzyme conjugates
Rabbit anti-BLV serum was kindly supplied by D. Por-
etelle, Department of Microbiology, University of Brus-
els, Gembloux, Belgium. Monkey anti-SIV serum (ADP
16, antiserum to SIVmac 251) from E. J. Stott was ob-
ained from the NIBSC Centralized Facility for AIDS Re-
gents supported by EU Programme EVA (Contract
MH4 97/2515) and the UK Medical Research Council.
oat anti-rabbit IgG (A-3687) and affinity-isolated rabbit
nti-monkey IgG (A-1929) alkaline phosphatase conju-
ates (Sigma Inc., St. Louis, MO) were obtained commer-
ially and used as second antibodies.
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